{"transactions":[{"id":4623713,"issuer":{"id":9265,"kind":"organization","name":"Electra Therapeutics, Inc.","symbol":"ETRA"},"owners":[{"id":183848,"kind":"person","name":"Parry Graham","position":1,"cik":"0002153366","reported_name":"Parry Graham","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Series A Convertible Preferred Stock","published_at":"2026-09-21T22:17:32.000Z","date":"2026-09-21","kind":"exercise","planned":false,"acquired":false,"shares":85504,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of  Series A Convertible Preferred Stock (the \"Preferred Stock\") converted automatically into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The Preferred Stock had no expiration date."},{"field":"shares","element":"transactionShares","label":"F1","text":"7,125 of the shares (\"Restricted Shares\") shall be subject to vesting as follows: 1/4th of the Restricted Shares shall vest monthly commencing from September 2, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of  Series A Convertible Preferred Stock (the \"Preferred Stock\") converted automatically into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of  Series A Convertible Preferred Stock (the \"Preferred Stock\") converted automatically into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of  Series A Convertible Preferred Stock (the \"Preferred Stock\") converted automatically into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The Preferred Stock had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"7,125 of the shares (\"Restricted Shares\") shall be subject to vesting as follows: 1/4th of the Restricted Shares shall vest monthly commencing from September 2, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":85504},"source":{"system":"sec-edgar","filing":"0002153366-26-000006","document":"form4-09212026_100928.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2153366/000215336626000006/form4-09212026_100928.xml","form_type":"4"}},{"id":4623712,"issuer":{"id":9265,"kind":"organization","name":"Electra Therapeutics, Inc.","symbol":"ETRA"},"owners":[{"id":183848,"kind":"person","name":"Parry Graham","position":1,"cik":"0002153366","reported_name":"Parry Graham","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-09-21T22:17:32.000Z","date":"2026-09-21","kind":"exercise","planned":false,"acquired":true,"shares":85504,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"7,125 of the shares (\"Restricted Shares\") shall be subject to vesting as follows: 1/4th of the Restricted Shares shall vest monthly commencing from September 2, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of  Series A Convertible Preferred Stock (the \"Preferred Stock\") converted automatically into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The Preferred Stock had no expiration date."}],"balance_after":85504,"source":{"system":"sec-edgar","filing":"0002153366-26-000006","document":"form4-09212026_100928.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2153366/000215336626000006/form4-09212026_100928.xml","form_type":"4"}}]}